Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non-Current Assets: 2019-2025

Historic Non-Current Assets for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $369.4 million.

  • Harmony Biosciences Holdings' Non-Current Assets fell 8.95% to $369.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.4 million, marking a year-over-year decrease of 8.95%. This contributed to the annual value of $419.9 million for FY2024, which is 16.53% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Non-Current Assets of $369.4 million as of Q3 2025, which was down 11.34% from $416.7 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Non-Current Assets high stood at $419.9 million for Q4 2024, and its period low was $149.0 million during Q4 2021.
  • In the last 3 years, Harmony Biosciences Holdings' Non-Current Assets had a median value of $369.4 million in 2025 and averaged $369.9 million.
  • Over the last 5 years, Harmony Biosciences Holdings' Non-Current Assets had its largest YoY gain of 115.38% in 2021, and its largest YoY loss of 9.25% in 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' Non-Current Assets (Quarterly) stood at $149.0 million in 2021, then spiked by 83.61% to $273.6 million in 2022, then skyrocketed by 31.72% to $360.4 million in 2023, then increased by 16.53% to $419.9 million in 2024, then declined by 8.95% to $369.4 million in 2025.
  • Its Non-Current Assets stands at $369.4 million for Q3 2025, versus $416.7 million for Q2 2025 and $412.8 million for Q1 2025.